Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

The combined treatments were highly effective for improving atrophic acne scars.

Trichoscopy effectively distinguishes between severe and mild male pattern hair loss.

Better diagnostic tools and treatment guidelines are needed for segmental vitiligo and related pigment issues.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Laser treatment improved scalp skin condition with no side effects.

Dr. Russell Knudsen's system classifies hair grafts by class, shape, and size for clearer communication in hair restoration surgery.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Tigason improved hair growth in a boy with monilethrix without side effects.

The TPAP method effectively categorizes androgenetic alopecia patients with high accuracy, but needs real-world validation.

Sunlight simulation causes skin inflammation, with different skin types reacting at different levels of exposure.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

The document's conclusion cannot be provided because the content is not accessible.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

The man's occipital hair loss was due to temporal triangular alopecia, not alopecia areata.

Trichodysplasia spinulosa is a rare skin condition linked to weakened immune systems, mostly in organ transplant patients.

Trichoscopy can reliably distinguish between alopecia areata and trichotillomania.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Treatment type and patch size affect hair regrowth patterns in alopecia areata.

Tinea infections need proper diagnosis and treatment with topical or oral antifungals based on severity and location.

Fragile hair in children is rarely linked to trichothiodystrophy (TTD).

Classifying alopecia helps diagnose and treat different types of hair loss accurately.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.